USU Conference Systems, International Conference on Tropical Medicine and Infectious Diseases (ICTROMI) 2017

Font Size: 
Optimalization and Validiton of High Performance Liquid Chromatography Method for Analyzing 25-Desacetyl Rifampicin in Human Urine
lily lily

Last modified: 2017-10-15


Objective:A selective, reproducibility, efektive, sensitive, simple and fast of High Performance Liquid Chromatography (HPLC) was developed, optimized and validated to analyze 25-Desacetyl Rifampicin (25-DR) in human urine which is a tuberculosis patient. Materials and Methods: The separation was performed by HPLC Agilent Technologies with column Agilent Eclipse XDB-C18 and mobile phase of 65:35 v/v methanol:0.01 M sodium phosphate buffer pH 5.2, at 254 nm and flow rate of 0.8 ml/min. Result: The mean retention time was 3,016 minutes. The method was linear from 2–10 μg/ml 25-DR with correlation coefficient of 0.9978. Standard deviation, relative standard deviation and coefficient variation of 2, 6, 10 μg/ml 25-DR were 0-0.0829, 0-3.1752, 0-0.0317%, respectively. The recovery of 5, 7, 9 μg/ml 25-DR was 80.8661, 91.3480 and 111.1457%, respectively. Limits of detection (LoD) and quantification (LoQ) were 0.51 and 1.7 μg/ml, respectively. Conclusion: The method has fulfilled the validity guidelines of the International Conference on Harmonization (ICH) bioanalytical method which includes parameters of specificity, linearity, precision, accuracy, LoD and LoQ. The developed method is suitable for pharmacokinetic analysis of various concentrations of 25-DR in human urine.